Wachtell, Lipton, Rosen & Katz

Wachtell, Lipton, Rosen & Katz advises boards of directors and senior executives on executive compensation issues within the context of M&A, divestitures, and complex corporate transactions. The firm handles a wide range of corporate governance challenges, including those posed by shareholder activists, proxy battles, and executive succession planning. Leading the New York-based team, Jeannemarie O’Brien is acclaimed for her executive compensation and benefits expertise in transactions involving financial services firms. Adam Shapiro and David Kahan focus on M&A, corporate governance, and executive employment agreements. Michael Schobel has a broad industry reach, with significant experience in banking, finance, technology, and pharmaceuticals, including his notable role in Pfizer’s $43 billion acquisition of Seagen; he shares this broad industry expertise with Amanda Toy. Erica Bonnett offers guidance on securities law compliance, compensation disclosures, and the structuring of executive employment contracts.